+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


China Synthetic Biology Market 2019-2025

  • ID: 5116668
  • Report
  • February 2020
  • Region: China
  • Orion Market Research Private Limited


  • Desktop Genetics, Ltd.
  • GenScript Biotech Corp.
  • Merck KGaA
  • Synthetic Genomics, Inc.
  • Twist Bioscience Corp.
  • Vedanta Biosciences, Inc.
China Synthetic Biology Market Size, Share & Trends Analysis Report, By Product (Enabling Product, Core Product, and Enabled Product), By Technologies (Gene Synthesis & Sequencing, Genome Engineering, Bioinformatics, and Others), By Application (Medical Application, Industrial Application, Food & Agriculture, and Environmental Applications) and Forecast Period 2019-2025.

The China synthetic biology market is expected to grow at a significant rate during the forecast period. In China, the synthetic biology market is still at its nascent stage, with emerging development in the biotechnology field. Major factors that are expected to fuel the market growth are due to the funding provided by the Chinese government on various projects related to synthetic biology, including Artificial Synthetic Cell Factory and Minimal genome of E. coli and its synthesis. The synthetic biologics market in China is at its developing stage; therefore, the growth of the market is mainly dependent on the research and development activities performed in the nation.

Some of the major research institutes working towards the development of synthetic biology technology in the country are Tsinghua University, Peking University, Tianjin University, Nankai University, Jiangnan University, Beijing University Chemical Technology, Nanjing University of Technology, and Shanghai Institutes for Biological Sciences. Chinese government plays a significant role in providing funds. The National High-tech Research and Development Project, National Science Foundation of China (NSFC), and the National Program on Key Basic Research Project provide funding for R&D of synthetic biology in China. Chinese government is planning to increase the research and development spending from 1.5% of GDP in 2014 to 2.5% in 2020

The China synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling product, core product, and enabled product. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and xeno nucleic acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical application, industrial application, food & agriculture, and environmental applications.

Research Methodology:

The market study of the China synthetic biology is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for pharmaceutical companies, drug manufacturers, biotechnology companies, chemical and biofuel industry, academic and government research institutes, food and agriculture industries, potential investors and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. China Synthetic Biology Market Research and Analysis by Product.
2. China Synthetic Biology Market Research and Analysis by Technology.
3. China Synthetic Biology Market Research and Analysis by Application.

The Report Covers:
  • Comprehensive Research Methodology of the China synthetic biology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the China synthetic biology market.
  • Insights about market determinants which are stimulating the China synthetic biology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Desktop Genetics, Ltd.
  • E. I. du Pont de Nemours and Co.
  • GenScript Biotech Corp.
  • Ginkgo Bioworks (The Organism Co)
  • Merck KGaA
  • Synthetic Genomics, Inc.
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corp.
  • Vedanta Biosciences, Inc.
Note: Product cover images may vary from those shown